Hopes are high for a treatment, which could come much quicker than a vaccine
Scientists around the globe are racing to develop tests, treatments, and vaccines to combat the COVID-19 disease.
Near term, tests are the priority. Beyond testing, regulators are trying to get treatments approved as quickly and safely as possible to serve as a bridge to a vaccine, which is likely to take 12 months, according to the U.S. FDA Commissioner Stephen Hahn.
Health-care experts broadly agree that a treatment is likely to come before a vaccine. “If a good treatment emerges, whatever it is, we expect regulators to prioritize expeditious review,” Laura Sutcliffe, a UBS health-care analyst said in a research note. —Julianna Tatelbaum